Skip to main navigation Skip to search Skip to main content

CY 4031: A Phase 3, Multi-National, Double-Blind, Randomized, Placebo-Controlled, Stratified, Parallel Group, Study to Evaluate the Safety, Tolerability, and Efficacy of Tirasemtiv in Patients with ALS

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date07/9/15 → 12/30/18

Funding

  • Cytokinetics Incorporated: $75,802.55